1. Safe perioperative tamoxifen use in autologous breast free flap reconstruction: systematic review and meta-analysis

   • Theresa K. Webster
   • Stephanie C. Roth
   • Sameer A. Patel

   Review 14 March 2022 Pages: 241 - 251

   

2. Invasive lobular carcinoma: an understudied emergent subtype of breast cancer

   • Jason A. Mouabbi
   • Amy Hassan
   • Rachel M. Layman

   Review 26 March 2022 Pages: 253 - 264

   

3. Radiation therapy for triple-negative breast cancer: emerging role of microRNAs as biomarkers and radiosensitivity modifiers. A systematic review

   • Nhu Hanh To
   • Hoang Quy Nguyen
   • On behalf of the TransAtlantic Radiation Oncology Network (TRONE) & Association of Radiotherapy, and Oncology of the Mediterranean Area (AROME)

   Review 09 April 2022 Pages: 265 - 279

   

4. Clinical trial data and emerging strategies: HER2-positive breast cancer

   • Sonia Pernas
   • Sara M. Tolaney

   Review 09 April 2022 Pages: 281 - 291

5. Health care professionals overestimate the risk for locoregional recurrences after breast cancer treatment depending on their specialty

   • Jet W. Ankersmid
   • Pauline E. R. Spronk
   • Sabine Siesling

   Preclinical study Open access 13 March 2022 Pages: 293 - 303

   

6. PGM5P3-AS1 regulates MAP1LC3C to promote cell ferroptosis and thus inhibiting the malignant progression of triple-negative breast cancer

   • Liqiang Qi
   • Bo Sun
   • Su Lu

   Preclinical Study 24 March 2022 Pages: 305 - 318

   

7. The early-stage triple-negative breast cancer landscape derives a novel prognostic signature and therapeutic target

   • Yun-Song Yang
   • Yi-Xing Ren
   • Zhi-Ming Shao

   Preclinical study 25 March 2022 Pages: 319 - 330

   

8. Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer

   • Ridho Assidicky
   • Unal Metin Tokat
   • Ozgur Sahin

   Preclinical study 25 March 2022 Pages: 331 - 348

   

9. PIK3CA-AKT pathway predominantly acts in developing ipsilateral breast tumor recurrence long after breast-conserving surgery

   • Hiroshi Nakagomi
   • Masayuki Inoue
   • Masao Omata

   Preclinical study 25 March 2022 Pages: 349 - 359

   

10. Multi-omics analyses provide novel biological insights to distinguish lobular ductal types of invasive breast cancers

    • Ambily Sivadas
    • Victor C. Kok
    • Ka-Lok Ng

    Preclinical study 29 March 2022 Pages: 361 - 379

    

11. Predictive value of topoisomerase II alpha protein for clinicopathological characteristics and prognosis in early breast cancer

    • Yun Wu
    • Yiqun Han
    • Binghe Xu

    Clinical trial 16 March 2022 Pages: 381 - 392

    

12. Predictive and prognostic effect of HO-1 expression in breast cancer patients undergoing neoadjuvant chemotherapy

    • Qixing Tan
    • Qinghong Qin
    • Changyuan Wei

    Clinical trial 18 March 2022 Pages: 393 - 403

    

13. B7 homolog 3 induces lung metastasis of breast cancer through Raf/MEK/ERK axis

    • Shuai Wang
    • Xinyan Zhang
    • Ruimei Sun

    Clinical trial 21 March 2022 Pages: 405 - 416

    

14. Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen

    • Brittany Bychkovsky
    • Alison Laws
    • Tari A. King

    Clinical trial 04 April 2022 Pages: 417 - 427

    

15. Higher risk tumor features are not associated with higher nodal stage in patients with estrogen receptor-positive, node-positive breast cancer

    • Linda Ye
    • Dennis Rünger
    • Maggie L. DiNome

    Clinical trial 07 April 2022 Pages: 429 - 436

    

16. Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer

    • Luc Dirix
    • Andy Buys
    • Peter Vermeulen

    Clinical trial Open access 09 April 2022 Pages: 437 - 444

    

17. Trends in surgical treatment of early-stage breast cancer reveal decreasing mastectomy use between 2003 and 2016 by age, race, and rurality

    • Mya L. Roberson
    • Hazel B. Nichols
    • Whitney R. Robinson

    Epidemiology 14 March 2022 Pages: 445 - 454

    

18. Adherence of long-term breast cancer survivors to follow-up care guidelines: a study based on real-world data from the SURBCAN cohort

    • Paula Santiá
    • Anna Jansana
    • SURBCAN Group

    Epidemiology Open access 15 March 2022 Pages: 455 - 465

    

19. Trajectories of objectively measured physical function among older breast cancer survivors in comparison with cancer-free controls

    • Juhua Luo
    • Stephen J. Carter
    • Michael Hendryx

    Epidemiology 26 March 2022 Pages: 467 - 476

    

20. Alcohol consumption, smoking, and invasive breast cancer risk after ductal carcinoma in situ

    • Kristina M. Jordahl
    • Kathleen E. Malone
    • Christopher I. Li

    Epidemiology 27 March 2022 Pages: 477 - 484

21. Mutational spectrum of breast cancer susceptibility genes among women ascertained in a cancer risk clinic in Northeast Brazil

    • Gabriela E. S. Felix
    • Rodrigo Santa Cruz Guindalini
    • Olufunmilayo I. Olopade

    Epidemiology Open access 30 March 2022 Pages: 485 - 494

    

22. Multivariate analysis of independent roles of socioeconomic status, occupational physical activity, reproductive factors, and postmenopausal hormonal therapy in risk of breast cancer

    • Sushmita Katuwal
    • Juha Tapanainen
    • Eero Pukkala

    Epidemiology Open access 02 April 2022 Pages: 495 - 505

    

23. Rate of breast biopsy referrals in female BRCA mutation carriers aged 50 years or more: a retrospective comparative study and matched analysis

    • Adi Pomerantz
    • Daliah Tsoref
    • Rinat Yerushalmi

    Epidemiology Open access 07 April 2022 Pages: 507 - 514

    

24. The clinical impact of MRI on surgical planning for patients with in-breast tumor recurrence

    • Amanda Sutherland
    • Ashley Huppe
    • Kelsey E. Larson

    Epidemiology 12 April 2022 Pages: 515 - 522

25. HER2-positive apocrine carcinoma of the breast: a population-based analysis of treatment and outcome

    • Faruk Skenderi
    • Mohamad Alhoda Mohamad Alahmad
    • Semir Vranic

    Brief Communication Open access 30 March 2022 Pages: 523 - 533